CapsoVision director sells 1,200 shares in June

CapsoVision, Inc director Joanne Carol Imperial reported an open-market sale of 1,200 shares of Common Stock on June 8, 2026 at an average price of $7.1555 per share.

Rhea-AI Filing Summary

CapsoVision, Inc director Joanne Carol Imperial reported an open-market sale of 1,200 shares of Common Stock on June 8, 2026 at an average price of $7.1555 per share. After this transaction, she directly holds 1,687 shares of CapsoVision stock.

The amended Form 4 notes that the filing is being made late because the company was not made aware of the reportable securities sale within the required timeframe.

Insider Trade Summary

Net Seller: 1,200 shares

Net Sell 1 txn

Insider Imperial Joanne Carol

Role Director

Sold 1,200 shs ($9K)

Type	Security	Shares	Price	Value
Sale	Common Stock	1,200	$7.1555	$9K

Holdings After Transaction: Common Stock — 1,687 shares (Direct)

Footnotes (1)

1. F1. This Form 4/A is being filed late because the Company was not made aware of the reportable securities sale within the required timeframe.

Key Figures

Shares sold: 1,200 shares Sale price per share: $7.1555 per share Shares held after transaction: 1,687 shares

3 metrics

Shares sold 1,200 shares Open-market sale of CapsoVision Common Stock on June 8, 2026

Sale price per share $7.1555 per share Average price for the June 8, 2026 open-market sale

Shares held after transaction 1,687 shares Director’s direct ownership following the reported sale

Key Terms

Form 4/A, open-market sale, Common Stock

3 terms

Form 4/A regulatory

"This Form 4/A is being filed late because the Company was not made aware..."

Form 4/A is an amended filing that corrects or updates an earlier Form 4, the mandatory report that insiders (like company executives, directors, or large shareholders) must file when their ownership stakes change. Think of it as an edited receipt showing who bought or sold stock and when; investors use it to track insider confidence, detect potential conflicts, and spot trading patterns that might signal future company prospects.

open-market sale financial

"transaction_action: open-market sale, transaction_code_description: Sale in open market..."

An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.

Common Stock financial

"security_title: Common Stock for the reported transaction"

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did CapsoVision (CV) report on this Form 4/A?

CapsoVision disclosed an open-market sale of 1,200 shares by a director. Director Joanne Carol Imperial sold 1,200 shares of CapsoVision Common Stock on June 8, 2026, as reported in this amended Form 4 filing.

At what price were the CapsoVision (CV) shares sold in the reported insider trade?

The 1,200 CapsoVision shares were sold at $7.1555 per share. The filing specifies that director Joanne Carol Imperial executed an open-market sale of Common Stock at this average price on June 8, 2026.

How many CapsoVision (CV) shares does the director hold after this transaction?

After the sale, the director directly holds 1,687 CapsoVision shares. The Form 4/A states that Joanne Carol Imperial’s direct ownership position in CapsoVision Common Stock stands at 1,687 shares following the June 8, 2026 transaction.

Who is the insider involved in the CapsoVision (CV) Form 4/A filing?

The insider is director Joanne Carol Imperial of CapsoVision, Inc. She is identified in the filing as a director, not an officer, and is the reporting person for the June 8, 2026 open-market sale of Common Stock.

Why was this CapsoVision (CV) Form 4/A filed as an amendment and noted as late?

The filing states it is late because the company was not informed in time. The footnote explains that CapsoVision was not made aware of the reportable securities sale within the required timeframe, leading to this amended Form 4/A.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 07/01/2026 - 09:21 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Imperial Joanne Carol

(Last) (First) (Middle)

C/O CAPSOVISION, INC.

18805 COX AVENUE, SUITE 250

(Street)

SARATOGA CALIFORNIA 95070

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
CapsoVision, Inc [ CV ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/08/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)
06/08/2026

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock(1)	06/08/2026		S		1,200	D	$7.1555	1,687	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. This Form 4/A is being filed late because the Company was not made aware of the reportable securities sale within the required timeframe.

Remarks:

	/s/ Kang-Huai (Johnny) Wang, Attorney-in-Fact for Joanne Imperial	07/01/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)